The LSI USA Emerging MedTech Summit brings together investors, industry leaders, and executives from emerging medical technology companies to explore the latest trends driving innovation in the MedTech and health sectors. The program offers valuable insight into the business, regulatory, and intellectual property considerations impacting medical device development and commercialization—providing important context for advising clients across the MedTech ecosystem.
Greenberg Traurig Shareholders Chris Bolten and Robert Ward will speak on the panel “Successful IP Strategies for Innovators” on March 17 at 9:00 a.m. PT at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, California.